Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GridAI TechnologiesGRDX +1.08%26 PS Ratio is 128.71 as of Aug. 19, 2026, which is 4% above its 10-year median of 124.04. GuruFocus rates GRDX with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 932 Biotechnology companies, GridAI Technologies ranks worse than 86.8% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, GridAI Technologies's share price is $3.99.
GridAI Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.03. Hence, GridAI Technologies's PS Ratio for today is 128.71.
The historical rank and industry rank for GridAI Technologies's PS Ratio or its related term are showing as below:
GRDX'
s PS Ratio Range Over the Past 10 Years
Min: 67.42 Med: 124.04 Max: 233.64
Current: 124.19
During the past 12 years, GridAI Technologies's highest PS Ratio was 233.64. The lowest was 67.42. And the median was 124.04.
GRDX's PS Ratio is ranked worse than 86.8% of 932
companies
in the Biotechnology industry
Industry Median: 9.315
vs GRDX: 124.19
GridAI Technologies (NAS:GRDX) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
GridAI Technologies PS Ratio Related Terms
GridAI Technologies PS Ratio Historical Data
* Premium members only.
The historical data trend for GridAI Technologies's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, GridAI Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GridAI Technologies PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GridAI Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where GridAI Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
GridAI Technologies's Share Price of today is $3.99. GridAI Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
GridAI Technologies (GRDX) has a PS Ratio of 128.71 as of Aug. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on GridAI Technologies and its competitors. This is near median its historical median of 124.04. Over the past decade, GridAI Technologies' PS Ratio has ranged from 67.42 to 233.64. According to the industry distribution chart, GridAI Technologies ranks #809 out of 932 companies in the Biotechnology industry, placing it in the top 86.8%.
Is GridAI Technologies' PS Ratio too high?
GridAI Technologies' current PS Ratio of 128.71 is near median its 10-year median of 124.04. Over the past 10 years, this metric has ranged from a low of 67.42 to a high of 233.64. The Biotechnology industry median PS Ratio is 9.32. GridAI Technologies' value of 128.71 is 1281.7% above this industry median. Based on the distribution chart, GridAI Technologies ranks #809 out of 932 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, GridAI Technologies has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does GridAI Technologies' PS Ratio compare to CELU and NRSN?
According to the Biotechnology industry distribution chart, GridAI Technologies ranks #809 out of 932 companies for PS Ratio. This places GridAI Technologies in the lower half of its industry. The industry median PS Ratio is 9.32. GridAI Technologies' value of 128.71 is 1281.7% above this benchmark. Historically, GridAI Technologies' own PS Ratio has ranged from 67.42 to 233.64 over the past decade. While the company's 10-year median is 124.04 vs. the industry median of 9.32, GridAI Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.32, based on 932 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GridAI Technologies's current PS Ratio of 128.71 is 1281.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on GridAI Technologies and its competitors. For the Biotechnology industry, the median PS Ratio is 9.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GridAI Technologies's current PS Ratio is 128.71, which is near median its own 10-year median of 124.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GridAI Technologies stock overvalued right now?
GridAI Technologies (GRDX) has a current PS Ratio of 128.71. The current PS Ratio is 128.71, which is near median its 10-year median of 124.04 and 1281.7% above the Biotechnology industry median of 9.32. GridAI Technologies' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For GridAI Technologies (GRDX), the current PS Ratio is 128.71 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
26GF Score
Get the complete analysis for GRDX
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDX has been successfully added to your 
